Trial Profile
A Phase II Single-centre Study of IBsolvMIR (dextran sulfate-low molecular weight) in auto-islet Transplant for Patients With Chronic Pancreatitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2014
Price :
$35
*
At a glance
- Drugs Dextran sulfate (Primary)
- Indications Pancreas transplant rejection
- Focus Therapeutic Use
- Sponsors TikoMed
- 02 Sep 2014 New trial record